ANI
19 Sep 2022, 14:55 GMT+10
Mumbai (Maharashtra) [India], September 19 (ANI): Indian stocks extended their losses for the fourth straight day to start a fresh week in the red.
At the time of writing this report, Sensex and Nifty were trading 0.1 per cent lower each. Among the Nifty 50 companies, 25 declined and the rest 25 advanced this morning, National Stock Exchange data showed.
The benchmark indices - Sensex and Nifty - settled 1.8-1.9 per cent lower on Friday.
Market participants are not aggressively participating and are largely shying away from making large bets, especially on concerns of aggressive global monetary policy tightening by various central banks to avert recessionary fears.
Three of the largest five economies will hold their central bank meetings during this week, including the US, Japan and the UK. Investors will keep a close on the monetary policy stances of these economies.
Consumer inflation in the US though declined marginally in August to 8.3 per cent from 8.5 per cent in July but is way above the 2 per cent goal. Several senior officials in the US central bank Federal Reserve recently said that another interest rate hike is imminent during the two-day monetary policy meeting that will start on TuesdayInflation in the UK is currently at 9.9 per cent.
These elevated inflation numbers give clear signs that the respective central bank will raise interest rates to contain price rises. Raising interest rates is a monetary policy instrument that typically helps suppress demand in the economy, thereby helping the inflation rate decline.
Inflation, both retail and wholesale, is high in India too, which may necessitate further interest rate hikes by the Reserve Bank of India.
As per schedule, the next three-day monetary policy meeting will be held during September 28-30.
"The market is likely to take a decisive trend only after the Fed policy announcement on 21st September. The market expects the Fed to raise rates by 75 bp and reiterate its hawkish stance. But since the market is going into the event with light positions and no positive expectations any positive data or comment may act as a trigger for a relief rally after the Fed announcement," said V K Vijayakumar, Chief Investment Strategist at Geojit Financial Services. (ANI)
Get a daily dose of Oklahoma City Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Oklahoma City Sun.
More InformationANKARA, Turkey: During a meeting, Michael Evans, President of the Alibaba Group, told Turkish President Tayyip Erdogan that the Chinese ...
NEW YORK: This week, the Wall Street Journal (WSJ) reported that U.S. electric vehicle (EV) maker Tesla and Saudi Arabia ...
NEW YORK, New York - Interest rates could stay higher for longer, but there is the possibility of rate cuts ...
STOCKHOLM, Sweden: Days before the Riksbank, Sweden's central bank, is expected to again raise interest rates, the Swedish krona hit ...
NEW ORLEANS, Louisiana: As Midwest farmers prepare to harvest crops and send tons of grain downriver to the Gulf of ...
JAKARTA, INDONESIA: Government data released this week showed that as imports, such as raw materials and capital goods, declined more ...
SEOUL, South Korea: Thousands of South Korean educators and school staff gathered in Seoul over the weekend to demand increased ...
WARSAW, Poland: As part of European Union (EU) sanctions imposed against Russia over its invasion of Ukraine, Poland banned all ...
MONTGOMERY, Alabama: Last week, Alabama's school chief, Superintendent Eric Mackey, said that under new reading benchmarks to move to fourth ...
WASHINGTON D.C.: Last week, the Federal Reserve said its losses surpassed the US$100 billion mark and will likely continue to ...
ARLINGTON, Virginia: This week, the U.S. State Department approved the potential sale of drone-related munitions and other systems to Canada ...
BETHESDA, Maryland: This week, the US National Institutes of Health (NIH) said that it started early-stage human trials on FluMos-v2, ...